Janux Therapeutics Inc

NASDAQ:JANX  
16.11
+0.27 (+1.70%)
Earnings Announcements

Janux Therapeutics Posts Q3 Loss Per Share Of $0.26

Published: 11/09/2021 21:42 GMT
Janux Therapeutics Inc (JANX) - Janux Therapeutics Reports Business Highlights and Third Quarter 2021 Financial Results.
Janux Therapeutics Inc- Qtrly Loss per Share $0.26.
Revenue is expected to be $0.65 Million
Adjusted EPS is expected to be -$0.26

Next Quarter Revenue Guidance is expected to be $1.3 Million
Next Quarter EPS Guidance is expected to be -$0.36

More details on our Analysts Page.